CYP2C9 polymorphisms impair acenocoumarol metabolism, but do not increase bleeding risk.

JF van der Heijden, S Schmits, MGH Remkes, BA Hutten, PH Reitsma

Research output: Contribution to journalMeeting AbstractOther research output

Original languageEnglish
Pages (from-to)149A-149A
Number of pages1
JournalBlood
Volume100
Issue number11
Publication statusPublished - 16 Nov 2002
Event44th Annual Meeting of the American-Society-of-Hematology - PHILADELPHIA, Netherlands
Duration: 6 Dec 200210 Dec 2002

Cite this